- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07597044
Evaluation of Sensitivity and Color Change of Different Protocols of In-office Dental Bleaching
Přehled studie
Postavení
Podmínky
Detailní popis
Two weeks before the bleaching procedures, selected volunteers from the city of Nova Friburgo, (Rio de Janeiro, Brazil) received a dental screening and a dental prophylaxis with pumice and water in a rubber cup and signed an informed consent form.
This was a randomized, single-blind (evaluators), parallel and equivalence trial with an equal allocation rate between groups.
A total of 71 participants were examined in a dental chair to check if they met the inclusion and exclusion criteria. A total of 40 participants were included in this study. The participants were randomly divided in the 40-minutes or 2x20-minutes groups.
During the in-office sessions, participants had the gingival tissue isolated of the teeth using a light-cured resin dam (Opal Dam, Ultradent Products International, Salt Lake, Utah, USA). After that, the 40% hydrogen peroxide gel (Opalescence Boost, Ultradent) was applied in one 40-min application according to the manufacturer's directions in all upper and lower incisors, canines and premolars, or was applied in the same teeth, but during 2 x 20-min applications, with no interval between them. After 20 minutes, the bleaching gel was removed with water spray before the second 20 minutes application. After 7 days this procedure was repeated using the same protocols.
Color evaluation was performed before and 30 days after the end of the bleaching treatment using a subjective (value oriented shade guide Vita Lumin, Vita Zahnfabrik, Bad Sackingen, Germany) and an objective method (Easyshade spectrophotometer, Vident, Brea, CA, USA). Color evaluation was done in a room under artificial lightning conditions without interference from outside light.
For the subjective examination, the shadeguide's 16 tabs were arranged from highest (B1) to lowest (C4) value. Changes in the scale were treated as representing a continuous and approximately linear ranking. Color was measured in the middle third of the facial surface of the right upper canine at baseline and 30 days after bleaching to calculate the variations in color towards the lighter end of the scale (Delta Shade Guide Units - DSGU).
One calibrated operator measured the color in all participants using the Vita Easyshade spectrophotomer (Easyshade, Vident, Brea, CA, USA) before and 30 days after the bleaching therapy. The L*, a* and b* parameters were recorded. L* represents the value from 0 (black) to 100 (white) and a* and b* represent the shade, where a* is the measurement along the red-green axis and b* is the measurement along the yellow-blue axis. Color change was calculated between the two assessment periods (DE) using the formula: DE = [(DL*)2 + (Da*)2 + (Db*)2]1/2.
The patients recorded their perception of TS during the first and second bleaching sessions using the visual analogue scale VAS. This scale employs a 10-cm horizontal line with words "no pain" at one end and "worst pain" at the opposite end. Participants recorded whether they experienced TS during the treatment up to 1 h after the bleaching, from 1 h to 24 hand from 24h to 48 h after bleaching. In the 30-day recall, patients were also asked if they experienced pain during this 30-day period. As two bleaching sessions were performed, the VAS score obtained in both bleaching sessions was considered for statistical purposes. These values
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Rio de Janeiro
-
Nova Friburgo, Rio de Janeiro, Brazílie, 28625-650
- Universidade Federal Fluminense - School of Dentistry
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
The selected volunteers should:
- Present Good general state of health
- Be at least 18 years of age
- Have an acceptable oral hygiene
- Present the upper and lower arches without absence of teeth of first premolar right to the left first premolar.
- Have anterior teeth with any kind of restoration.
- Be No smoker
- Have the upper right canine with color 2M2 or darker
Exclusion Criteria:
The selected volunteers should not:
- Have medical history of diseases that can affect the results of the study
- Have made use of cigarettes in the last 30 days
- Have some important pathology in the oral cavity
- Be pregnant
- Be breastfeeding
- Have moderate advanced periodontal disease;
- Have consumed drugs, alcool or any medication that can cover the results, as other types of anti-inflammatories or painkillers;
- Have used products indicated for dental sensitivity, as desensitizing toothpaste or similar product
- Present gingival recession
- Present exacerbated hypersensitivity history
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Bleaching 40 minutes
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 40 minutes according to manufacturer's instructions.
|
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 40 minutes according to manufacturer's instructions.
|
|
Experimentální: Bleaching 2x20 minutes
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 20 minutes, will be removed (with water) and a new application of 20 minutes will be made.
|
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 20 minutes, will be removed with water, and another application of 20 minutes will be made.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Tooth sensitivity
Časové okno: 1 hour after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
1 hour after dental bleaching session
|
|
Tooth sensitivity
Časové okno: 24 hours after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
24 hours after dental bleaching session
|
|
Tooth sensitivity
Časové okno: 48 hours after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
48 hours after dental bleaching session
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Color change with scale
Časové okno: 30 days after dental bleaching session
|
Objective color evaluation comparing tooth color against a comercial color scale from A1 to D4
|
30 days after dental bleaching session
|
|
Color change with spectrophotometer
Časové okno: 30 days after dental bleaching session
|
Objective color evaluation using a spectrophotometer
|
30 days after dental bleaching session
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: MARCOS O BARCELEIRO, PhD, Full Professor
Publikace a užitečné odkazy
Obecné publikace
- Carey CM. Tooth whitening: what we now know. J Evid Based Dent Pract. 2014 Jun;14 Suppl:70-6. doi: 10.1016/j.jebdp.2014.02.006. Epub 2014 Feb 13.
- de Paula EA, Loguercio AD, Fernandes D, Kossatz S, Reis A. Perioperative use of an anti-inflammatory drug on tooth sensitivity caused by in-office bleaching: a randomized, triple-blind clinical trial. Clin Oral Investig. 2013 Dec;17(9):2091-7. doi: 10.1007/s00784-013-0918-2. Epub 2013 Jan 31.
- de Paula EA, Nava JA, Rosso C, Benazzi CM, Fernandes KT, Kossatz S, Loguercio AD, Reis A. In-office bleaching with a two- and seven-day intervals between clinical sessions: A randomized clinical trial on tooth sensitivity. J Dent. 2015 Apr;43(4):424-9. doi: 10.1016/j.jdent.2014.09.009. Epub 2014 Sep 23.
- da Costa Poubel LA, de Gouvea CVD, Calazans FS, Dip EC, Alves WV, Marins SS, Barcelos R, Barceleiro MO. Pre-operative use of dexamethasone does not reduce incidence or intensity of bleaching-induced tooth sensitivity. A triple-blind, parallel-design, randomized clinical trial. Clin Oral Investig. 2019 Jan;23(1):435-444. doi: 10.1007/s00784-018-2452-8. Epub 2018 Apr 25.
- de Mendonca RP, Baliza JR, Burey A, Cavalcante LM, Loguercio AD, Calazans FS, Barceleiro MO. In vitro analysis of the pH stability of dental bleaching gels during in-office procedures. J Clin Exp Dent. 2021 Jan 1;13(1):e22-e29. doi: 10.4317/jced.57367. eCollection 2021 Jan.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- UFFBleachingProtocols
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Citlivost zubů
-
Hereditary Neuropathy FoundationNáborCharcot-Marie-Tooth nemoc | Charcot-Marie-Tooth Disease, typ IA | Charcot-Marie-Tooth Disease Type 2A | Charcot-Marie-Tooth | Charcot-Marie-Tooth Disease, typ IB | Charcot-Marie-Tooth Disease Type 2 | Charcot-Marie-Tooth Disease, typ 2C | Charcot-Marie-Tooth Disease Type 2A2B | Charcot-Marie-Tooth Disease... a další podmínkySpojené státy
-
University College, LondonUniversity of IowaNeznámýCharcot-Marie-Tooth Disease, typ IA | Charcot-Marie-Tooth Disease Type 2A | Charcot-Marie-Tooth Disease, typ IB | Charcot-Marie-Tooth Disease, Type XSpojené království
-
University Medical Center GoettingenNáborCharcot Marie Tooth Disease | CMT (Charcot Marie Tooth Disease) | CMT | Charcot Marie Tooth Disease (CMT)Německo
-
University Hospital, Clermont-FerrandDokončenoNeuropatie Charcot-Marie-Tooth typu 1AFrancie
-
University Hospital, Clermont-FerrandDokončenoNeuropatie Charcot-Marie-Tooth typu 1AFrancie
-
Tasly GeneNet Pharmaceuticals Co., LtdDokončenoCharcot-Marie-Tooth Typ 1AČína
-
University Hospital, Strasbourg, FranceZatím nenabíráme
-
University Medical Center GoettingenNáborCMT - Charcot-Marie-Tooth Disease | CMT1A | CMT (Charcot Marie Tooth Disease)Německo
-
Nationwide Children's HospitalZatím nenabírámeNeuropatie Charcot-Marie-Tooth typu 1ASpojené státy
-
Damascus UniversityDokončenoShlukování, Tooth | Malokluze, třída I/IISýrie
Klinické studie na Standard in-office tooth bleaching
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)UkončenoLeukémieSpojené státy
-
University of AlbertaAlberta Health services; Alberta Innovates Health Solutions; Covenant Health,...NáborNovorozenecký abstinenční syndromKanada
-
Marshfield Clinic Research FoundationCenters for Disease Control and PreventionDokončeno
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)DokončenoDiabetes mellitus, typ 1Spojené státy
-
National Cancer Institute (NCI)UkončenoRecidivující melanom | Melanom fáze IVSpojené státy
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)DokončenoLeukémieSpojené státy
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)DokončenoLymfom | Myelodysplastické syndromy | Leukémie | Myelodysplastické/myeloproliferativní novotvarySpojené státy
-
Washington University School of MedicineUniversity of Colorado, Denver; University of California, Berkeley; University... a další spolupracovníciAktivní, ne nábor
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)DokončenoLymfom | Myelodysplastické syndromy | Leukémie | Mnohočetný myelom a novotvar z plazmatických buněkSpojené státy
-
Swiss Group for Clinical Cancer ResearchDokončenoTestování chemosenzitivity k určení léčby u pacientů s rakovinou vaječníků stadia III nebo stadia IVRakovina vaječníkůŠvýcarsko